Vertex Pharmaceuticals, Transocean, And 'One Of The Best Companies' In Staples: CNBC's 'Final Trades'

On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners chose Transocean Ltd RIG, after the company reported its first-quarter results. EBITDA was “a lot better than expected,” he said.

“Rig day rates are going up. This is going to be a home run,” Lebenthal added.

Benzinga's analyst ratings data shows a consensus Neutral rating on Transocean.

Joseph Terranova of Virtus Investment Partners said Vertex Pharmaceuticals Incorporated VRTX had a “strong earnings report.” The stock has the potential to trade above $400, Terranova added.

Check out other stocks making moves in the premarket.

Jenny Harrington of Gilman Hill Asset Management said Procter & Gamble Co. PG was “one of the best companies that reported in staples.” The company’s organic growth of 7% helped “beat earnings, revenues, and margins,” while pushing the guidance higher, she added.

Also Read: Elon Musk Says People In The Future 'Probably Won't Even Need To Pay' For Drugs To Get High